Latest Postherpetic neuralgia Stories
NEWARK, Calif., Aug. 19, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced Judge Joel A. Pisano of the U.S.
All studies on track for completion and final study reports by November 2014 MALVERN, Pa., Aug.
NEWARK, Calif., July 25, 2014 /PRNewswire/ -- Depomed, Inc.
ReportsnReports.com adds “Cebranopadol (Neuropathic Pain) - Forecast and Market Analysis to 202” to its store. Dallas, TX (PRWEB) July 20, 2014 Neuropathic
Opinion Expected "In Short Order" NEWARK, Calif., July 17, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced that on July 17, 2014, Judge Joel A.
The Company expects the studies, along with the PK study, to be completed in the 4th quarter of 2014 MALVERN, Pa., July 14, 2014 /PRNewswire/ -- SCILEX Pharmaceuticals,
NEWARK, Calif., June 18, 2014 /PRNewswire/ -- Depomed, Inc.
NEWARK, Calif., June 10, 2014 /PRNewswire/ -- Depomed, Inc.
MELBOURNE, Australia and STAMFORD, Connecticut, June 3, 2014 /PRNewswire/ -- Spinifex Pharmaceuticals, a pain drug development company, today announces that it has appointed
NEWARK, Calif., May 27, 2014 /PRNewswire/ -- Depomed, Inc.
Herpes zoster (or zoster), is known as shingles or zona and is a viral disease characterized by painful skin rash with blisters in a limited area on one side of the body. Initial infection causes chickenpox. Once chickenpox is over the virus remains in the body and can cause shingles. It can become latent in the nerve cell bodies and sometimes in the dorsal root, cranial nerve, or autonomic ganglion. Years after initial infection, another breakout can cause a painful rash. The rash usually...
- To give a box on the ear to.